08:00 , Nov 9, 1998 |  BC Week In Review  |  Clinical News

CaroRx SIgA monoclonal antibody against Streptococcus mutans: began a phase I/II trial of its plantibody

Planet Biotechnology Inc., Mountain View, Calif.   Product: CaroRx SIgA monoclonal antibody against Streptococcus mutans   Indication: Prevent infection by oral bacteria to prevent tooth decay   Status: Planet began a Phase I/II trial of its...
07:00 , May 4, 1998 |  BC Week In Review  |  Clinical News

CaroRx SIgA monoclonal antibody: Phase I

Researchers reported in Nature Medicine that topical application of the SIgA antibody in the mouths of human patients prevented recolonization by Streptococcus mutans, the organism that contributes to cavities (see Technology Briefing, BioCentury Part I)....